PKG drug G1 is primarily utilized in the field of cancer research and therapy. It functions as a potent inhibitor of protein kinase G, which plays a significant role in cellular signaling pathways associated with tumor growth and progression. By targeting and inhibiting this enzyme, PKG drug G1 helps in disrupting the signaling mechanisms that promote cancer cell survival and proliferation. This makes it a valuable tool in preclinical studies aimed at understanding the molecular basis of cancer and in the development of targeted therapeutic strategies. Additionally, its application extends to exploring its potential in combination therapies, where it may enhance the efficacy of other anticancer agents by sensitizing cancer cells to treatment.